HDAC4: histone deacetylase 4
How Fast You Start and Get Your Medication If you want to start this week, speed is not a tiebreaker
The STEP (Semaglutide Treatment Effect in People with obesity) 1 trial was a randomized, placebo-controlled trial that evaluated the efficacy of once-weekly subcutaneous (SC) semaglutide 2.4 mg plus lifestyle interventions in adults with obesity without diabetes (n = 1961)
(Diabetes Care, 2022) found that patients prescribed semaglutide for weight management achieved 12.1% average weight loss at 12 months, while those prescribed Contrave achieved 4.8% weight loss over the same period
Endocrinology 156 , 39613970 (2015)
Professor Jonathan Benger, deputy chief executive and chief medical officer at NICE, said: Successful weight management doesnt end when medication stops or when someone completes a behavioural programme